Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 16, 2026 · Filed Nov 18, 2026
Dexcom's Chief Legal Compliance Off sold $142K of Dexcom shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$141,882
Shares × reported transaction price
18 days after results of Oct 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $81.61 on Nov 16, 2026, 42% above its 52-week low and 12% below its high, after a 6% drop over the previous 30 trading days
52-week range $57.56 (Apr 29, 2026) to $92.34 (Aug 21, 2026), 69% of the way up, from 251 adjusted closes. 30 trading days earlier: $86.90 on Oct 5, 2026. Describes the past only, not a forecast
RSI 48, 9% above its 200-day average, 3% under its 50-day average, 12% below the 52-week high, 20-day volatility 51% a year, against the S&P 500: −2 points over 1 month, −5 points over 3 months, +25 points over 6 months
From the adjusted closes up to Nov 16, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Oct 27, 2025 in the U.S. District Court, S.D. New York. A filing is an allegation, not a finding.
3 such cases were open. Prime v. DexCom, Inc., docket 1:25-cv-08912, via CourtListener (court records). Nature of suit 850, company named as first defendant
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Michael Brown (Officer) plans to sell ~$142K of Dexcom
Planned, from payInsider filing
Traded Nov 8 · filed 2 days later
Routine share withholding; mechanical by default.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.